Neuralstem

CUR NASDAQ
5.90
-2.60
-30.59%
盘后: 5.90 0 0.00% 19:58 07/19 EDT
开盘
8.00
昨收
8.50
最高
8.47
最低
5.28
成交量
48.43万
成交均量(3M)
2.39万
52周最高
31.80
52周最低
5.00
换手率
48.40%
市值
590.40万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Neuralstem CUR股票价格,Neuralstem股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Neuralstem, Inc. (Neuralstem) is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. The Company has approximately three assets: its NSI-189 small molecule program, its NSI-566 stem cell therapy program and its chemical entity screening platform. The Company's technology allows the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the treatment of central nervous system diseases and conditions. The Company is developing NSI-189 for the treatment of major depressive disorder (MDD) and other psychiatric and/or cognitive impairment indications associated with hippocampal atrophy. The Company's NSI-566 is indicated for amyotrophic lateral sclerosis (ALS), chronic spinal cord injury and motor deficits due to ischemic stroke.
展开 >

最近浏览

名称
价格
涨跌幅